AIM: To investigate how a complex network of CC chemokine ligands (CCLs) and their receptors influence the progression of tumor and metastasis. METHODS: In the present study, we used immunohistochemistry to examine the expression of CCL7, CCL8 and CCL21 in 194 gastric cancer samples and adjacent normal tissues. We analyzed their correlation with tumor metastasis, clinicopathologic parameters and clinical outcome. RESULTS: We found that the higher expression of CCL7 and CCL21 in cancer tissues than in normal tissues was significantly correlated with advanced depth of wall invasion, lymph node metastasis and higher tumor node metastasis stage. Moreover, Kaplan-Meier survival analysis revealed that CCL7 and CCL21 overexpression in cancer tissues was correlated with poor prognosis. CONCLUSION: These results suggest that overexpression of these two CC chemokine ligands is associated with tumor metastasis and serves as a prognostic factor in patients with gastric cancer.
AIM: To investigate how a complex network of CC chemokine ligands (CCLs) and their receptors influence the progression of tumor and metastasis. METHODS: In the present study, we used immunohistochemistry to examine the expression of CCL7, CCL8 and CCL21 in 194 gastric cancer samples and adjacent normal tissues. We analyzed their correlation with tumor metastasis, clinicopathologic parameters and clinical outcome. RESULTS: We found that the higher expression of CCL7 and CCL21 in cancer tissues than in normal tissues was significantly correlated with advanced depth of wall invasion, lymph node metastasis and higher tumor node metastasis stage. Moreover, Kaplan-Meier survival analysis revealed that CCL7 and CCL21 overexpression in cancer tissues was correlated with poor prognosis. CONCLUSION: These results suggest that overexpression of these two CC chemokine ligands is associated with tumor metastasis and serves as a prognostic factor in patients with gastric cancer.
Authors: Da-Woon Jung; Zhong Min Che; Jinmi Kim; Kyungshin Kim; Ki-Yeol Kim; Darren Williams; Jin Kim Journal: Int J Cancer Date: 2010-07-15 Impact factor: 7.396
Authors: Elina Azenshtein; Galia Luboshits; Sima Shina; Eran Neumark; David Shahbazian; Miguel Weil; Nely Wigler; Iafa Keydar; Adit Ben-Baruch Journal: Cancer Res Date: 2002-02-15 Impact factor: 12.701
Authors: Kristiane Wetzel; Sofie Struyf; Jo Van Damme; Tim Kayser; Annunciata Vecchi; Silvano Sozzani; Jean Rommelaere; Jan J Cornelis; Christiane Dinsart Journal: Int J Cancer Date: 2007-03-15 Impact factor: 7.396
Authors: Peter Schraml; Christoph Bucher; Heidi Bissig; Antonio Nocito; Philippe Haas; Kim Wilber; Steven Seelig; Juha Kononen; Michael J Mihatsch; Stefan Dirnhofer; Guido Sauter Journal: J Pathol Date: 2003-07 Impact factor: 7.996
Authors: Emese Zsiros; Priyanka Duttagupta; Denarda Dangaj; Hongzhe Li; Renee Frank; Thomas Garrabrant; Ian S Hagemann; Bruce L Levine; Carl H June; Lin Zhang; Ena Wang; Francesco M Marincola; Davide Bedognetti; Daniel J Powell; Janos Tanyi; Michael D Feldman; Lana E Kandalaft; George Coukos Journal: Clin Cancer Res Date: 2015-02-23 Impact factor: 12.531
Authors: Russell E Ericksen; Shannon Rose; Christoph Benedikt Westphalen; Wataru Shibata; Sureshkumar Muthupalani; Yagnesh Tailor; Richard A Friedman; Weiping Han; James G Fox; Anthony W Ferrante; Timothy C Wang Journal: Gut Date: 2013-05-31 Impact factor: 23.059